Full Paper
1H NMR (300 MHz, CDCl3): d=6.67 (m, 1H), 6.59 (m, 2H), 5.89 (s,
2H), 5.06 (m, 1H), 4.02 (q, J=7.2 Hz, 2H), 3.73 (m, 1H), 2.93 (m,
1H), 2.76 (m, 1H), 2.66–2.49 (m, 3H), 2.28 (m, 1H), 2.24 (m, 1H),
1.14 ppm (t, J=7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=206.3,
170.4, 148.4, 147.4, 132.7, 120.6, 108.8, 107.5, 101.4, 89.6, 61.1, 43.2,
42.9, 42.1, 34.9, 32.9, 14.1 ppm; HRMS: m/z calcd for C17H19NO7:
349.1162 [M]+; found: 349.1169 [M]+; HPLC (Chiralcel OD-H, isopro-
tion mixture was extracted with CH2Cl2. The organic layer was
washed with brine, dried over Na2SO4, filtered, and concentrated
under reduced pressure, and the crude product 2 was used for
next step without further purification. Methyl chloroformate
(51 mg, 0.468 mmol) was added to a solution of crude product 2
and triethylamine (59 mg, 0.585 mmol) in CH2Cl2 (5 mL) at 08C, and
the resulting solution was stirred at room temperature for 6 h. The
mixture was diluted with CH2Cl2. The organic layer was washed
with saturated aqueous NaHCO3 solution and brine. The organic
layer was dried over Na2SO4, filtered, and concentrated under re-
duced pressure, and the residue was purified by flash silica gel
chromatography (ethyl acetate/petroleum ether=1:3) to give 15
(84 mg, 53% (over two steps)) as a white powder. [a]2D0 = +16.5
panol/n-hexane=25:75, flow rate 0.8 mLminÀ1, l=220 nm): tmajor
30.586 min, tminor =34.880 min.
=
Ethyl 2-((7S,8S,9R)-9-(benzo[d][1,3]dioxol-5-yl)-8-nitro-1,4-
dithiaspiro[4.5]decan-7-yl)acetate (13)
1
Boron trifluoride etherate (170 mg, 0.12 mmol) was added to a solu-
tion of compound 3 (380 mg, 1.09 mmol) and 1,2-dithioethane
(102 mg, 1.09 mmol) in dry dichloromethane (6 mL). The resulting
solution was stirred at room temperature for 30 min. The mixture
was diluted with ether and saturated aqueous NaHCO3 solution,
and then the organic layer was washed with brine and dried over
Na2SO4, filtered, and concentrated under reduced pressure. The res-
idue was purified by flash silica gel chromatography (ethyl acetate/
petroleum ether=1:4) to give 13 (356 mg, 77%) as a white
powder. [a]2D0 = +2.6 (c=1.0 in CHCl3); 1H NMR (300 MHz, CDCl3):
d=6.68 (m, 3H), 5.94 (s, 2H), 4.90 (dd, J=17.4 Hz, J=5.1 Hz, 1H),
4.12 (m, 2H), 3.40 (m, 1H), 3.25 (m, 5H), 2.90 (m, 1H), 2.66 (m, 1H),
2.38 (m, 3H), 2.17 (m, 1H), 1.25 ppm (t, J=7.2 Hz, 3H); 13C NMR
(75 MHz, CDCl3): d=171.2, 148.0, 147.0, 133.1, 120.4, 108.6, 107.7,
101.1, 90.8, 64.2, 60.9, 50.1, 42.9, 41.8, 40.5, 37.8, 34.9, 33.6,
14.2 ppm; HRMS: m/z calcd for C19H23NO6S2: 425.0967 [M]+; found:
425.0953 [M]+.
(c=1.0 in CHCl3); H NMR (400 MHz, CDCl3): d=6.62 (m, 2H), 6.51
(m, 1H), 5.82 (s, 2H), 3.64 (m, 2H), 3.20 (m, 4H), 3.11 (m, 4H), 2.66
(m, 1H), 2.43 (m, 1H), 2.20 (m, 3H), 2.14 (m, 2H), 0.76 ppm (t, J=
6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=155.5, 147.4, 146.0,
136.6, 121.5, 108.2, 107.9, 100.7, 65.7, 62.1, 60.6, 48.1, 44.9, 44.4,
40.7, 40.3, 39.7, 36.9, 26.7, 14.1 ppm; HRMS: m/z calcd for
C20H25NO4S2: 407.1225 [M]+; found: 407.1234 [M]+.
(3aS,3a1S,12bR)-1,3,3a,4,5,12b-Hexahydrospiro[[1,3]dioxolo-
[4,5-j]pyrrolo[3,2,1-de]phenanthridine-2,2’-[1,3]dithiolan]-
7(3a1H)-one (1)
A mixture of 15 (35 mg, 0.086 mmol) and POCl3 (1 mL) was heated
at 908C for 16 h, and the mixture was slowly poured into cold
water and basified (pH 11) with 8% NaOH. The mixture was ex-
tracted with CH2Cl2 and washed with brine. The organic layer was
dried over Na2SO4, filtered, and concentrated under reduced pres-
sure, and the residue was purified by flash silica gel chromatogra-
phy (ethyl acetate/petroleum ether=2:1) to give 1 (26 mg, 85%)
(3a’S,7’R,7a’S)-7’-(Benzo[d][1,3]dioxol-5-yl)hexahydrospiro-
[[1,3]dithiolane-2,5’-indol]-2’(1’H)-one (14)
as
a
white powder. [a]D20 = +39.0 (c=1.0 in CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.39 (s, 1H), 6.54 (s, 1H), 5.92 (s, 2H), 4.07 (m,
1H), 3.48 (m, 1H), 3.30 (m, 4H), 3.16 (m, 1H), 2.97 (m, 1H), 2.67 (m,
1H), 2.61 (m, 1H), 2.34 (m, 1H), 2.20 (m, 1H), 2.03 (m, 1H),
1.92 ppm (m, 2H); 13C NMR (75 MHz, CDCl3): d=162.9, 150.4, 146.5,
136.7, 125.2, 108.6, 103.6, 101.5, 65.2, 59.6, 45.7, 41.9, 41.8, 40.2,
38.9, 37.6, 37.3, 30.7 ppm; HRMS: m/z calcd for C18H19NO3S2:
361.0806 [M]+; found: 361.0806 [M]+.
Zinc power (161 mg, 2.47 mmol, 3.5 equiv) and 10% HCl (2 mL)
were added to a solution of compound 13 (300 mg, 0.706 mmol)
in EtOH (10 mL), and the resulting solution was stirred at room
temperature for 24 h. After filtration, the filtrate was evaporated
under vacuum. Then 2m NaOH was added and extracted with
CH2Cl2. The organic phase was dried over anhydrous Na2SO4, fil-
tered, and concentrated under reduced pressure, and the crude
product was used for the next step without further purification.
CH3ONa (3.52 mmol, 190 mg) was added to a solution of the crude
product in CH3OH (5 mL), and the reaction mixture was stirred at
room temperature for 24 h. After removal of solvent, the mixture
was diluted with EtOAc and H2O. The organic layer was washed
with brine and dried over Na2SO4. The organic layer was filtered
and concentrated under reduced pressure, and the residue was pu-
rified by flash silica gel chromatography (ethyl acetate/petroleum
ether=2:1) to give 14 (172 mg, 70%) as a white powder. [a]2D0 = +
(3aR,3a1S,12bR)-3,3a,3a1,4,5,12b-Hexahydro-1H-
[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridin-7(2H)-one
(16)
Raney Ni (200 mg) was added to a solution of 15 (30 mg,
0.083 mmol) in EtOH (4 mL) and the resulting solution was stirred
under a hydrogen atmosphere at 608C for 60 h. After completion
of the reaction, the mixture was filtered and concentrated under
reduced pressure, and the residue was purified by flash silica gel
chromatography (ethyl acetate/petroleum ether=2:1) to give 16
(19 mg, 85%) as a white powder. [a]2D0 = +150.0 (c=1.0 in CHCl3);
1H NMR (300 MHz, CDCl3): d=7.45 (s, 1H), 6.66 (s, 1H), 5.98 (s, 2H),
4.11 (dd, J=11.7 Hz, J=7.5 Hz, 1H), 3.45 (dd, J=12.6 Hz, J=9.0 Hz,
1H), 3.21 (m, 1H), 2.64 (m, 1H), 2.45 (m, 1H), 2.12 (m, 1H), 1.97 (m,
1H), 1.82 (m, 1H), 1.79–1.62 (m, 4H), 1.34 ppm (m, 1H); 13C NMR
(75 MHz, CDCl3): d=162.7, 149.9, 145.9, 137.9, 124.9, 108.1, 103.4,
101.0, 60.5, 45.2, 36.9, 36.7, 30.4, 25.1, 22.8, 20.4 ppm; HRMS: m/z
calcd for C16H17NO3: 271.1208 [M]+; found: 271.1211 [M]+.
1
51.3 (c=1.0 in CHCl3); H NMR (300 MHz, CDCl3): d=6.57 (m, 3H),
5.88 (s, 2H), 5.53 (brs, 1H), 3.31 (m, 1H), 3.17 (m, 4H), 2.68 (m, 3H),
2.34 (m, 2H), 2.08 ppm (m, 3H); 13C NMR (75 MHz, CDCl3): d=
177.0, 148.2, 146.8, 135.3, 120.9, 108.6, 107.6, 101.1, 65.4, 59.1, 47.1,
46.9, 40.9, 40.3, 37.6, 35.5, 34.2 ppm; HRMS: m/z calcd for
C17H19NO3S2: 349.0806 [M]+; found: 349.0799 [M]+.
(3a’S,7’R,7a’S)-Ethyl 7’-(benzo[d][1,3]dioxol-5-
yl)hexahydrospiro[[1,3]dithiolane-2,5’-indole]-1’(6’H)-carbox-
ylate (15)
(+)-a-Lycorane
LiAlH4 (74 mg, 1.95 mmol, 5 equiv) was added to a solution of 14
(136 mg, 0.39 mmol) in dry THF (5 mL) and the resulting solution
was stirred under reflux for 12 h. 1m NaOH was added. The reac-
LiAlH4 (11 mg, 0.275 mmol, 5 equiv) was added to a solution of 16
(15 mg, 0.055 mmol) in dry THF (5 mL) and the resulting solution
Chem. Eur. J. 2014, 20, 6112 – 6119
6117
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim